Key quantitative variables contributing to LC group classification included the neutralizing capacity of IgGs against SARS-CoV-2, the levels of CRP, thrombin, prothrombin, and REG3A, as well as the number of vaccine doses and having received a combination of vaccine types rather than a single vaccine type. The gene discussed is REG3A; the disease is laryngotracheoesophageal cleft.